Navigation Links
New clues uncover how 'starvation hormone' works, investigators at UT Southwestern report
Date:12/27/2010

DALLAS Dec. 26, 2010 New findings by UT Southwestern Medical Center researchers may solve a 17-year-old mystery about how the so-called "starvation hormone" affects multiple biological systems, including preventing insulin sensitivity and promoting cell survival.

The results connect multiple observations about how the hormone adiponectin functions and eventually could lead to new treatments for conditions ranging from diabetes and weight loss to heart disease and cancer.

"Until now, there wasn't really an obvious connection between all these different phenomena," said Dr. Philipp Scherer, professor of internal medicine and cell biology and senior author of the study appearing online today and in a future edition of Nature Medicine.

In this study, the researchers used models of inducible cell suicide in both pancreatic beta cells, which produce insulin, and cardiomyocytes, which are specific muscle cells located in a part of the heart known as the myocardium, to determine how the single hormone could exert such different influences.

"This paper shows that the common theme among all these different activities relies on adiponectin's interaction with a specific subset of lipids known as ceramides," said Dr. Scherer, who directs the Touchstone Center for Diabetes Research.

Ceramides are a family of lipid molecules known to promote cell suicide, or apoptosis. High levels of ceramides have been shown to promote diabetes by sabotaging signaling pathways induced by insulin and killing beta cells.

When the researchers introduced adiponectin into cells, they found that the hormone triggers the conversion of ceramides from a destructive force into one that helps cells survive and inhibits cell death.

"Adiponectin essentially provides a makeover of this ugly cousin," Dr. Scherer said.

Dr. William Holland, lead author and postdoctoral fellow in internal medicine, said the new findings have implications for the treatment of numerous diseases including diabetes and cancer.

"One beauty of this study is that the findings are in both animal models and in vitro," Dr. Holland said. "We were able to show using these models of apoptosis in the beta cell and the heart that we can protect those cells from cell death with adiponectin."

Adiponectin, which Dr. Scherer discovered in 1994, not only controls sensitivity to insulin but also is known to play an integral role in metabolism and obesity. Prior research has shown that when adiponectin levels are high, the body stores excess fat in adipocytes, or fat cells, to protect against possible starvation during lean times. These fat deposits lie primarily in the subcutaneous tissue.

As a person accumulates more fat, however, adiponectin levels decline. Once adiponectin levels start dropping, the body begins storing fat in dangerous places such as the heart, liver and muscle tissues where it can cause inflammation and pave the way for heart disease. That's why researchers think that adiponectin levels could be a good predictor of whether someone is at risk of developing diabetes, heart disease or cancer.

Overall, the new findings "endorse the idea that adiponectin is very important and is probably a key manipulator of lipid levels," Dr. Scherer said.


'/>"/>

Contact: Kristen Holland Shear
kristen.hollandshear@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert

Related medicine news :

1. CHOP experts collaborate in gene survey of childhood brain cancer; intriguing clues found
2. Fat yet muscular mouse provides clues to improving cardiovascular health
3. New 3-D model of RNA core domain of enzyme telomerase may offer clues to cancer, aging
4. New Clues to Possible Genetic Basis for ADHD
5. New Clues to Treating Ovarian Cancer Relapse
6. Hurts so good -- neural clues to the calming effects of self-harm
7. Long-Term Type 1 Diabetes Survivors Give Clues to the Disease
8. More Clues To Fibromyalgia Pain
9. Gene Mutation Offers Clues to Tamoxifen-Blood Clot Link
10. New Clues for Treating Ulcerative Colitis
11. Gene Mutations Offer Clues to Autoimmune Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance ... greater Dallas, Miami, and Raleigh regions, is organizing an extended charity drive to ... and deadly chromosome abnormality. , After struggling since birth with several health challenges, ...
(Date:10/13/2017)... , ... October 13, 2017 , ... While it’s often ... a problem. Fortunately, an inventor from Austin, Texas, has identified a solution. , She ... in darkness or restricted lighting. As such, it eliminates the need to turn on ...
(Date:10/13/2017)... ... 13, 2017 , ... PurhealthRX , a leading Health and Nutrition Company, ... Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market by ... be easily incorporated into liquid products, while reducing costs to end users. , The ...
(Date:10/13/2017)... CT (PRWEB) , ... October 13, 2017 , ... ... long-term care services, staged a mock evacuation of the facility as part of a ... Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for ... for action towards gender equality at their inaugural Summit in New York City in ... reached a social audience of over 3 million. To watch the Mobilize Women video, ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)...  South Korean-based healthcare product Development Company I.M. Lab ... Kickstarter. The device will educate the user about ,proper, ... efficiency compared to the dated and pricey CPR training ... of the compression for a more informed CPR training. ... raise $5,000. cprCUBE ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
Breaking Medicine Technology: